Suppr超能文献

基于世界卫生组织(WHO)2022 年标准评估未分类肾细胞癌的临床行为及其在计算机断层扫描和磁共振成像上的影像学表现。

Evaluation of the clinical behavior of unclassified renal cell carcinoma and its imaging findings on computed tomography and magnetic resonance imaging based on World Health Organization (WHO) 2022.

机构信息

Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan.

Department of Radiology, Keio University School of Medicine, Tokyo, Japan.

出版信息

Jpn J Radiol. 2024 Jan;42(1):78-86. doi: 10.1007/s11604-023-01484-1. Epub 2023 Aug 19.

Abstract

OBJECTIVES

To ascertain the clinical behaviors of unclassified renal cell carcinoma (RCC) and its characteristic imaging findings on CT and MRI.

METHODS

Subjects in this retrospective study were 10 patients who had received a histological diagnosis of unclassified RCC based on World Health Organization (WHO) 2022 and who had undergone CT and/or MRI prior to surgery. In terms of clinical behaviors, TNM classification, stage, postoperative recurrence, time to recurrence, and postoperative survival were evaluated. In terms of imaging findings, tumor size, growth pattern, CT density, dynamic contrast-enhancement (DCE) pattern, internal appearance, presence of a pseudocapsule, and signal intensity on MRI were evaluated. We compared clinical behaviors and imaging findings, and investigated associations between them.

RESULTS

One patient could not be followed-up due to death from other causes. Postoperative recurrence was observed in 4 patients, all of whom had Stage 3 RCC. In the remaining 5 patients without recurrence, all 5 patients showed Stage 2 or below. On imaging, unclassified RCC tended to be large (58.7 mm) and solid (100%), and heterogeneous interiors (80%), cystic degeneration (80%) and high intensity on diffusion-weighted imaging (DWI) (71.4%) were common. Comparing patients with and without recurrence, the following findings tended to differ between recurrence and recurrence-free groups: tumor size (73.4 ± 33.9 mm vs. 50.2 ± 33.9 mm, P = 0.286), growth pattern (invasive: 100% vs. 0%, expansive: 0% vs. 100%, P = 0.008 each), DCE pattern (progressive enhancement pattern, 66.7% vs. 0%, washout pattern, 0% vs. 66.7%, P = 0.135 each) and presence of a pseudocapsule (25% vs. 80%, P = 0.167).

CONCLUSION

The clinical behavior of unclassified RCC varies widely. Although imaging findings are also variable, findings of large, heterogeneous tumors with cystic degeneration and high intensity on DWI were common. Several imaging findings such as large size, invasive growth, progressive enhancement pattern and no pseudocapsule may enable prediction of prognosis in unclassified RCC.

摘要

目的

明确未分类肾细胞癌(RCC)的临床行为及其在 CT 和 MRI 上的特征性影像学表现。

方法

本回顾性研究纳入了 10 名患者,这些患者基于世界卫生组织(WHO)2022 年标准接受了组织学诊断为未分类 RCC,并在手术前接受了 CT 和/或 MRI 检查。在临床行为方面,评估了 TNM 分期、肿瘤分期、术后复发、复发时间和术后生存情况。在影像学表现方面,评估了肿瘤大小、生长方式、CT 密度、动态对比增强(DCE)模式、内部表现、假包膜的存在以及 MRI 的信号强度。我们比较了临床行为和影像学表现,并探讨了它们之间的关系。

结果

由于其他原因导致的死亡,1 名患者无法进行随访。4 名患者出现了术后复发,均为 RCC Ⅲ期。在其余 5 名未复发的患者中,所有患者均为 RCCⅡ期或以下。在影像学上,未分类 RCC 往往较大(58.7mm)且实性(100%),内部异质性(80%)、囊性变性(80%)和弥散加权成像(DWI)高信号(71.4%)较为常见。比较复发和无复发患者,以下影像学表现在复发组和无复发组之间存在差异:肿瘤大小(73.4±33.9mm vs. 50.2±33.9mm,P=0.286)、生长方式(浸润性:100% vs. 0%,外生性:0% vs. 100%,P=0.008 各)、DCE 模式(渐进增强模式:66.7% vs. 0%,廓清模式:0% vs. 66.7%,P=0.135 各)和假包膜的存在(25% vs. 80%,P=0.167)。

结论

未分类 RCC 的临床行为差异很大。尽管影像学表现也存在差异,但大、不均匀、伴囊性变性和 DWI 高信号的肿瘤较为常见。一些影像学表现,如较大的肿瘤大小、侵袭性生长、渐进增强模式和无假包膜,可能有助于预测未分类 RCC 的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26f/10764380/4f2f702aec11/11604_2023_1484_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验